Skip to content

Lifecore Biomedical, Inc. LFCR Financing Cash Flow

Financing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.09B+1,172%
ADMA Biologics logo
ADMA BiologicsADMA
-$10.13M-42.1%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$12.67M+104%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$16.9M+17,320%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$1.85M-35.5%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s financing cash flow?
Lifecore Biomedical, Inc. (LFCR) reported financing cash flow of -$256K in Q1 2026.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.